Difficulty: Medium
Average Score: 80%
Practice
Which one of the following is least likely to be a mechanism of cancer cell resistance to antineoplastic drugs?
Correct answer
B
Rationale
In the context of understanding cancer cell resistance to antineoplastic drugs, it is crucial for students to grasp the various mechanisms by which cancer cells can develop resistance. In this case, option B, "Decreased activity of activating enzymes," is the least likely mechanism of cancer cell resistance to antineoplastic drugs.
The correct answer is right because activating enzymes play a crucial role in converting prodrugs into their active form, which can then target cancer cells. Therefore, a decreased activity of activating enzymes would actually result in decreased drug efficacy rather than resistance.
Regarding the other options:
- A) Change in properties of a target enzyme: This is a common mechanism where alterations in the target enzyme can reduce the binding affinity of the drug, rendering it less effective.
- C) Increase in drug-metabolizing cytochrome P450: An increase in drug-metabolizing enzymes can enhance drug metabolism and clearance, reducing drug concentrations in cancer cells.
- D) Increase in DNA repair: Cancer cells can develop resistance by enhancing their DNA repair mechanisms, leading to the repair of drug-induced DNA damage and survival of the cells.
Understanding these mechanisms of resistance is essential for clinicians to tailor treatment strategies and overcome drug resistance in cancer patients. By comprehending these concepts, students can better appreciate the complexity of cancer biology and treatment, ultimately improving patient outcomes.
The correct answer is right because activating enzymes play a crucial role in converting prodrugs into their active form, which can then target cancer cells. Therefore, a decreased activity of activating enzymes would actually result in decreased drug efficacy rather than resistance.
Regarding the other options:
- A) Change in properties of a target enzyme: This is a common mechanism where alterations in the target enzyme can reduce the binding affinity of the drug, rendering it less effective.
- C) Increase in drug-metabolizing cytochrome P450: An increase in drug-metabolizing enzymes can enhance drug metabolism and clearance, reducing drug concentrations in cancer cells.
- D) Increase in DNA repair: Cancer cells can develop resistance by enhancing their DNA repair mechanisms, leading to the repair of drug-induced DNA damage and survival of the cells.
Understanding these mechanisms of resistance is essential for clinicians to tailor treatment strategies and overcome drug resistance in cancer patients. By comprehending these concepts, students can better appreciate the complexity of cancer biology and treatment, ultimately improving patient outcomes.